Biogen

Biogen Inc. is a global biotechnology corporation headquartered in Massachusetts. The firm, which was founded in 1978 by a small group of visionary scientists, finds, develops, produces, and markets new medicines for patients with neurological and neurodegenerative illnesses all over the world. Biogen also develops and markets biosimilars for sophisticated biologics. Biogen is now one of the world's oldest independent biotechnology businesses.

Biogen made $14.4 billion in sales in 2019. Total sales increased 1% to $3.53 billion in the first quarter of 2020, compared to $3.49 billion in the same quarter last year. The corporation generated around $3.68 billion in the second quarter of 2020, a 2% increase over the second quarter of 2019. Revenue of $3.38 billion in the third quarter of 2020 was down 6% from the third quarter of 2019, including a 1% adverse currency effect.

Founded: 1978

Headquarters: Cambridge, Massachusetts, United States

Market cap: 39.72B USD

Website: https://www.biogen.com/en_us/home.html